The report covers forecast and analysis for the human microbiome market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the human microbiome market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the human microbiome market on a global level.
In order to give the users of this report a comprehensive view of the human microbiome market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new service type launch, agreements, partnerships, collaborations & joint ventures, research & development, service type and regional expansion of major participants involved in the market.
The study provides a decisive view of the human microbiome market by segmenting it into the product, application, disease type, and region. All the segments have been analyzed based on present and the future trends and the market is estimated from 2018 to 2024. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further categorization into major countries including the U.S., the UK, Germany, France, China, Japan, India, Brazil, etc. This segmentation includes demand for human microbiome market based on all segments in all the regions and countries.
The key players in the global human microbiome market are AOBiome LLC, Second Genome, Seres Therapeutics, Osel, Inc., Metabiomics Corp., uBiome, Inc., Rebiotix, Inc., Enterome, Vedanta Biosciences, Synthetic Biologics, Inc., and Biosciences
This report segments the global human microbiome market as follows:
Global Human Microbiome Market: Product Segment Analysis
- Probiotics
- Prebiotics
- Medical Foods
- Supplements
- Others
Global Human Microbiome Market: Application Segment Analysis
- Therapeutics
- Diagnostics
Global Human Microbiome Market: Disease Type Segment Analysis
- Obesity
- Diabetes
- Autoimmune Disorder
- Metabolic & Gastrointestinal Disorder
- Cancer
- Others
Global Human Microbiome Market: Regional Segment Analysis
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
